Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
about
Development of an instrument to assess the impact of an enhanced experiential model on pharmacy students' learning opportunities, skills and attitudes: a retrospective comparative-experimentalist study.Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings.Disparity implications of Medicare eligibility criteria for medication therapy management servicesThe effect of active learning methodologies on the teaching of pharmaceutical care in a Brazilian pharmacy faculty.Evaluation and review of pharmacoeconomic models.Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence.Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.Historical trend of disparity implications of Medicare MTM eligibility criteria.Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.A cost-effectiveness evaluation of hospital discharge counseling by pharmacists.Register-based indicators for potentially inappropriate medication in high-cost patients with excessive polypharmacy.[Economic evaluation of pharmacotherapeutic follow-up in type 2 diabetes mellitus patients in community pharmacies].Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil.
P2860
Q33327311-0BB5836E-D83C-4685-AC47-7250C18BB945Q33572003-3910F6FA-039B-4F81-83CD-0E233DA5CFC4Q34022273-A60148B8-7AAB-4683-9AF1-47339FA6ADB0Q35601889-41EFA350-FA28-40E9-9F22-159FDED9A313Q35871850-6FED8406-4C53-46C7-A931-9FAF2F608225Q36013046-02191B4C-3536-4025-972D-7017F084E30EQ36243328-7B880154-CFCE-427E-AE41-D4197E7A0DBEQ36546254-5A063CC3-102A-4E78-B31E-A7E9571B7683Q37381150-0B101C6F-26E2-440A-A44F-F21F2FB14092Q37944198-67EC232A-087F-4B00-964C-32EF31AA8FFFQ38366452-957E7406-A1F0-4452-95C0-5D79CE69DF8EQ43234786-4081EE28-A343-4A8F-A1FF-C314A94302E2Q48315614-98D8B184-93D9-408C-8A7D-EC7AA140A18EQ55005060-9816111F-7188-4675-8AE5-902AD8744EDF
P2860
Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
@ast
Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
@en
type
label
Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
@ast
Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
@en
prefLabel
Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
@ast
Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
@en
P1433
P1476
Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.
@en
P2093
Joel W Hay
Lida R Etemad
P304
P356
10.1046/J.1524-4733.2003.64255.X
P577
2003-07-01T00:00:00Z